2022 AIM 临床适用性指南:针对单基因和多因素疾病的基因检测

2022-03-06 AIM Specialty Health aimspecialtyhealth

AIM 单基因和多因素基因检测临床适用性指南中涉及的检测包括单基因检测、多基因诊断面板、与多因素疾病相关的变异检测、染色体微阵列分析和人类白细胞抗原 (HLA) 组织相容性检测.

中文标题:

2022 AIM 临床适用性指南:针对单基因和多因素疾病的基因检测

英文标题:

AIM CLINICAL APPROPRIATENESS GUIDELINES FOR GENETIC TESTING FOR SINGLE-GENE AND MULTIFACTORIAL CONDITIONS

发布机构:

AIM Specialty Health

发布日期:

2022-03-06

简要介绍:

AIM 单基因和多因素基因检测临床适用性指南中涉及的检测包括单基因检测、多基因诊断面板、与多因素疾病相关的变异检测、染色体微阵列分析和人类白细胞抗原 (HLA) 组织相容性检测.

相关资料下载:
[AttachmentFileName(sort=1, fileName=GT01-Single-Gene-and-Multifactorial-Conditions-March-6-2022.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2659e1c0025a524d, title=2022 AIM 临床适用性指南:针对单基因和多因素疾病的基因检测, enTitle=AIM CLINICAL APPROPRIATENESS GUIDELINES FOR GENETIC TESTING FOR SINGLE-GENE AND MULTIFACTORIAL CONDITIONS, guiderFrom=aimspecialtyhealth, authorId=0, author=, summary=AIM 单基因和多因素基因检测临床适用性指南中涉及的检测包括单基因检测、多基因诊断面板、与多因素疾病相关的变异检测、染色体微阵列分析和人类白细胞抗原 (HLA) 组织相容性检测., cover=https://img.medsci.cn/20220726/1658764831253_1608702.jpg, journalId=0, articlesId=null, associationId=3006, associationName=AIM Specialty Health, associationIntro=AIM Specialty Health® 提供临床解决方案,推动适当、安全和负担得起的护理。AIM 为 50 个州、哥伦比亚特区和美国领土的超过 6800 万会员提供服务,通过使用基于证据的临床指南和为提供者及其患者提供实时决策支持来促进最佳护理。我们的平台采用来自 Applied Pathways(AIM 的全资子公司)的复杂临床规则引擎,可在包括放射学、心脏病学、肿瘤学、特种药物、睡眠医学、肌肉骨骼护理在内的一系列不断扩大的临床领域中显着节省护理成本、康复、外科手术和基因检测。, copyright=0, guiderPublishedTime=Sun Mar 06 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #777777;">AIM 单基因和多因素基因检测临床适用性指南中涉及的检测包括单基因检测、多基因诊断面板、与多因素疾病相关的变异检测、染色体微阵列分析和人类白细胞抗原 (HLA) 组织相容性检测.</span></p>, tagList=[TagDto(tagId=878, tagName=基因检测), TagDto(tagId=92682, tagName=单基因)], categoryList=[CategoryDto(categoryId=69, categoryName=检验病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3746, appHits=29, showAppHits=0, pcHits=181, showPcHits=3717, likes=0, shares=6, comments=3, approvalStatus=1, publishedTime=Sun Jul 31 20:59:00 CST 2022, publishedTimeString=2022-03-06, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Tue Jul 26 00:03:10 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 15:26:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=GT01-Single-Gene-and-Multifactorial-Conditions-March-6-2022.pdf)])
GT01-Single-Gene-and-Multifactorial-Conditions-March-6-2022.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1235871, encodeId=e5d512358e1da, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/29/f48081e2c7622ec35cbcc4345041d752.jpg, createdBy=0e865110940, createdName=涧西源长, createdTime=Mon Aug 01 09:20:04 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235841, encodeId=729c123584195, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0a35172122, createdName=146dbb97m23暂无昵称, createdTime=Mon Aug 01 00:33:11 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2022-08-01 涧西源长

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1235871, encodeId=e5d512358e1da, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/29/f48081e2c7622ec35cbcc4345041d752.jpg, createdBy=0e865110940, createdName=涧西源长, createdTime=Mon Aug 01 09:20:04 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235841, encodeId=729c123584195, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0a35172122, createdName=146dbb97m23暂无昵称, createdTime=Mon Aug 01 00:33:11 CST 2022, time=2022-08-01, status=1, ipAttribution=)]
    2022-08-01 146dbb97m23暂无昵称

    好用

    0